Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2018 (Event Date: February 26, 2018)
Context: The Company entered into Amendment No. 3 to its Credit Agreement, modifying financial covenants and credit facility terms.
Key Financial Metrics and Debt Structure
This filing details debt restructuring rather than operational performance metrics. Specific revenue, profit, or cash flow figures are not provided in this document.
- Revolving Credit Commitments: Extended commitments reduced to $650 million; total revolving credit commitments now stand at $840 million (including the non-extended portion).
- Financial Covenant: The EBITDA to interest expense ratio covenant was removed. It was replaced by a First Lien Net Debt to EBITDA ratio covenant.
- Covenant Thresholds:
- Current Maximum: 5.25 to 1.0
- July 1, 2018: 5.0 to 1.0
- January 1, 2019: 4.75 to 1.0
- January 1, 2020: 4.5 to 1.0
- July 1, 2020: 4.25 to 1.0
Material Changes Versus Prior Period
The primary material change is the amendment of the Credit Agreement dated July 25, 2007 (as previously amended). Key changes include:
- Covenant Replacement: Removal of the EBITDA to interest expense ratio and implementation of a First Lien Net Debt to EBITDA ratio.
- Commitment Reduction: Reduction of extended revolving credit commitments to $650 million.
- Asset Sale Proceeds: Modification of rules regarding the retention of asset sale proceeds. Proceeds must now be applied to prepay term loans based on pro forma leverage ratios:
- 100% prepayment required if First Lien Net Debt to EBITDA is $\ge$ 4.5 to 1.0.
- 50% prepayment required if ratio is between 4.0 to 1.0 and 4.5 to 1.0.
- No prepayment required if ratio is < 4.0 to 1.0.
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain forward-looking guidance on revenue or earnings. The focus is strictly on the terms of the amended credit facility.
Risks and Contingencies:
- Leverage Constraints: The Company is subject to stricter prepayment obligations on asset sales if leverage remains above 4.0 to 1.0, potentially limiting liquidity flexibility.
- Covenant Compliance: The Company must maintain the First Lien Net Debt to EBITDA ratio below the specified declining thresholds to avoid default.
Investor Verification Checklist
- Verify the Company's current First Lien Net Debt to EBITDA ratio to assess compliance with the new 5.25 to 1.0 threshold.
- Review the full text of Amendment No. 3 (Exhibit 10.1) for specific definitions of "First Lien Net Debt" and "EBITDA" used in the new covenant.
- Assess the impact of the reduced revolving credit commitments ($650 million extended) on the Company's liquidity position.
- Monitor future asset sale activities to determine if mandatory term loan prepayments will be triggered based on the new leverage tiers.